Literature DB >> 3310930

The first 100 liver transplants at UCLA.

R W Busuttil1, J O Colonna, J R Hiatt, J J Brems, G el Khoury, L I Goldstein, W J Quinones-Baldrich, I H Abdul-Rasool, K P Ramming.   

Abstract

A clinical program in liver transplantation was begun at UCLA in 1984 after a period of laboratory investigation. The first 100 orthotopic liver transplants (OLT) were performed in 83 patients (43 adults and 40 children) between February 1, 1984 and November 1, 1986. Donors and recipients were matched only for size and ABO blood group compatibility, with OLT performed across blood groups in 28 patients. Standard operative techniques were used, including venous-venous bypass in adults. Arterial reconstruction was performed using an aortic Carrel patch or "branch patch" in 65% of cases and by end-to-end or aortic conduit techniques in the remainder. The hepatic artery thrombosis rate was 5%. Biliary reconstruction was choledochocholedochostomy in 67 OLT and Roux-en-Y choledochojejunostomy in 33 (complication rate of 24% and 24%, respectively). Average lengths and ranges of donor liver ischemia, operating time, and blood replacement were 4 hours (range: 1-10 hours), 7.6 hours (range: 4-15 hours), and 17 units packed cells (range: 2-220 units). Immunosuppressive regimen was cyclosporine-steroid combination, with monoclonal anti-T-cell antibody (OKT3) used for refractory rejection. All patients had one or more complications: pulmonary (78%), infectious (51%), renal dialysis (25%), neurologic (22%). All patients had at least one episode of acute rejection, and 3.6% had chronic rejection. Retransplantation was needed in nine patients once and in four patients twice. The overall retransplant survival rate was 54%, and two of four patients who received a second retransplant are alive. Sixty-three of the 83 patients (76%) are alive (adults 72%, children 80%). The 1- and 2-year actuarial survival rate is 73% (adults 68%, children 78%). Thirty-eight of 43 patients (88%) who had transplantation in the past year are alive. Of 14 perioperative variables assessed as predictors of early mortality, only postoperative dialysis (p less than 0.0005) and presence of severe rejection (p less than 0.01) had statistical significance. Seventy per cent of adults returned to work, and 84% of children had normal or accelerated growth. A new program in liver transplantation provides a dramatic option in patient care and an academic stimulus to the entire medical center.

Entities:  

Mesh:

Year:  1987        PMID: 3310930      PMCID: PMC1493226          DOI: 10.1097/00000658-198710000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.

Authors:  A B Cosimi; S I Cho; F L Delmonico; M M Kaplan; R J Rohrer; R L Jenkins
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

2.  Liver transplantation at UCLA. Program development, organization, initiation, and early results.

Authors:  R W Busuttil; L D Memsic; W Quinones-Baldrich; J R Hiatt; K P Ramming
Journal:  Am J Surg       Date:  1986-07       Impact factor: 2.565

3.  Orthotopic liver transplantation for hepatobiliary malignancy. Report of three cases of special interest.

Authors:  J O Colonna; R A Ray; L I Goldstein; J R Hiatt; W Quinones-Baldrich; K P Ramming; R W Busuttil
Journal:  Transplantation       Date:  1986-11       Impact factor: 4.939

4.  Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; M A Nalesnik; D C Farhi; D H Van Thiel
Journal:  Surg Gynecol Obstet       Date:  1986-02

5.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

6.  Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis.

Authors:  J Neuberger; D G Altman; E Christensen; N Tygstrup; R Williams
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

7.  Liver transplantation across ABO blood groups.

Authors:  R D Gordon; S Iwatsuki; C O Esquivel; A Tzakis; S Todo; T E Starzl
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

8.  Liver transplantation without venous bypass.

Authors:  W J Wall; D R Grant; J H Duff; J L Kutt; C N Ghent; M S Bloch
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

9.  Biliary tract complications in human orthotopic liver transplantation.

Authors:  J Lerut; R D Gordon; S Iwatsuki; C O Esquivel; S Todo; A Tzakis; T E Starzl
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

10.  Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection.

Authors:  S J Knechtle; P C Kolbeck; S Tsuchimoto; A Coundouriotis; F Sanfilippo; R R Bollinger
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

View more
  31 in total

Review 1.  Biliary tract reconstruction in liver transplantation.

Authors:  K Yanaga; K Sugimachi
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Effect of a prior portasystemic shunt on subsequent liver transplantation.

Authors:  J J Brems; J R Hiatt; A S Klein; J M Millis; J O Colonna; W J Quinones-Baldrich; K P Ramming; R W Busuttil
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

3.  General surgery: advances in liver transplantation.

Authors:  C W Pinson
Journal:  West J Med       Date:  1989-08

4.  Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy.

Authors:  C P Charlton; E Buchanan; C E Holden; M A Preece; A Green; I W Booth; M J Tarlow
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

5.  WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation.

Authors:  Leonard Makowka; Linda Sher; Delawir Kahn; Thomas E Starzl; A G Tzakis; S Todo; J W Marsh; A Stieber; B Koneru; G B G Klintmalm; S M Staschak; S Iwatsuki; R D Gordon; D Van Thiel
Journal:  Hosp Rec Study       Date:  1988-06

6.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Basket removal of intraatrial catheter after liver transplantation: technical note.

Authors:  J Singer; P Joyce; J Brems
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jul-Aug       Impact factor: 2.740

8.  One thousand liver transplants. The lessons learned.

Authors:  R W Busuttil; A Shaked; J M Millis; O Jurim; S D Colquhoun; C R Shackleton; B J Nuesse; M Csete; L I Goldstein; S V McDiarmid
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

9.  Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience.

Authors:  J A Goss; C R Shackleton; K Swenson; N L Satou; B J Nuesse; D K Imagawa; M M Kinkhabwala; P Seu; J S Markowitz; S M Rudich; S V McDiarmid; R W Busuttil
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

10.  Significant influence of the primary liver disease on the outcomes of hepatic retransplantation.

Authors:  A Qasim; B M Zaman; J Geoghegan; D Maguire; O Traynor; J Hegarty; P A McCormick
Journal:  Ir J Med Sci       Date:  2008-11-04       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.